buttons in column example 2
Summary of guideline
Clinical Contents:
- Diagnosis
- Initial illness severity assessment
- Risk factors for severe illness
- SARS-CoV-2 co-infection
- Investigations
- Monitoring
- Respiratory support
- Medications and nasal suction
- Hydration and nutrition
- Discharge planning
- Prevention of RSV bronchiolitis
- Education modules
Technical Contents:
SUMMARY
Bronchiolitis is one of the most common reasons for hospital admission in Australian and Aotearoa New Zealand infants. The Australasian Bronchiolitis Guideline aims to provide evidence-based clinical guidance on the management of infants (<12 months) presenting or admitted to hospital with bronchiolitis. The recommendations are applicable to emergency departments (EDs), general paediatric wards, and intensive care units (ICUs) in Australasian hospitals. The guidance has been developed for clinicians working within these settings.
The Guideline recommendations are presented in the table below and can also be downloaded in three documents as above; (1) a detailed Full Guideline summarising the evidence underlying each recommendation, (2) Annexes to the Full Guideline, and (3) a Bedside Summary.
[table “” not found /]Disclaimer: The PREDICT Australasian Bronchiolitis Guideline aims to provide evidence-based clinical guidance for the management of infants (aged <12 months) with bronchiolitis, who have presented to an ED, or who have been admitted to a general paediatric ward or ICU (requiring treatment up to the point of mechanical ventilation) in an Australasian hospital. The content provided is not intended to replace personal consultation with, diagnosis and treatment by a qualified health care professional. Care should always be based on professional medical advice, appropriate for a patient’s specific circumstances.